CN1133293A - 铂配合物和包含该铂配合物的恶性肿瘤治疗药物 - Google Patents

铂配合物和包含该铂配合物的恶性肿瘤治疗药物 Download PDF

Info

Publication number
CN1133293A
CN1133293A CN95113167A CN95113167A CN1133293A CN 1133293 A CN1133293 A CN 1133293A CN 95113167 A CN95113167 A CN 95113167A CN 95113167 A CN95113167 A CN 95113167A CN 1133293 A CN1133293 A CN 1133293A
Authority
CN
China
Prior art keywords
platinum complex
compound
platinum
nmr
cyclohexanediamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95113167A
Other languages
English (en)
Chinese (zh)
Inventor
横井好一
茂木锦一
神谷英彦
大真理
水野博之
佐藤进
仓石忠幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN1133293A publication Critical patent/CN1133293A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN95113167A 1994-12-26 1995-12-25 铂配合物和包含该铂配合物的恶性肿瘤治疗药物 Pending CN1133293A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6322542A JPH08176176A (ja) 1994-12-26 1994-12-26 白金錯体及びこれを含有する悪性腫瘍治療剤
JP322542/94 1994-12-26

Publications (1)

Publication Number Publication Date
CN1133293A true CN1133293A (zh) 1996-10-16

Family

ID=18144839

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95113167A Pending CN1133293A (zh) 1994-12-26 1995-12-25 铂配合物和包含该铂配合物的恶性肿瘤治疗药物

Country Status (8)

Country Link
US (1) US5585511A (enExample)
EP (1) EP0720986B1 (enExample)
JP (1) JPH08176176A (enExample)
KR (1) KR960022546A (enExample)
CN (1) CN1133293A (enExample)
CA (1) CA2165895A1 (enExample)
DE (1) DE69513005T2 (enExample)
TW (1) TW302364B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001872A (en) * 1999-03-05 1999-12-14 Virginia Commonwealth University Water soluble transplatinum complexes with anti-cancer activity and method of using same
WO2005075489A1 (en) 2004-02-05 2005-08-18 Dabur Pharma Limited A process for the perparation of an anti-tumor platinum (ii) - complex

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921697A (ja) * 1982-06-24 1984-02-03 Yoshinori Kitani 新規な白金錯体
JPS59112995A (ja) * 1982-12-21 1984-06-29 Shionogi & Co Ltd 新規グリコ−ル酸白金錯体
JPS59222498A (ja) * 1983-06-01 1984-12-14 Shionogi & Co Ltd 新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
DE3477788D1 (en) * 1983-08-05 1989-05-24 Yoshinori Kidani Cytostatic platinum complexes
JPH0212497A (ja) * 1988-06-30 1990-01-17 Fuji Electric Co Ltd 前払い後払い共用のカードシステム
JPH02212497A (ja) * 1989-02-10 1990-08-23 Tanabe Seiyaku Co Ltd 新規白金錯体及びその製法
JP2740919B2 (ja) * 1989-03-30 1998-04-15 塩野義製薬株式会社 白金錯体およびこれらを有効成分として含有する抗腫瘍剤

Also Published As

Publication number Publication date
US5585511A (en) 1996-12-17
JPH08176176A (ja) 1996-07-09
DE69513005T2 (de) 2000-04-06
CA2165895A1 (en) 1996-06-27
EP0720986A1 (en) 1996-07-10
KR960022546A (ko) 1996-07-18
TW302364B (enExample) 1997-04-11
DE69513005D1 (de) 1999-12-02
EP0720986B1 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
CN1196687C (zh) Impdh酶抑制剂
CN1035829A (zh) (环烷基胺基)亚甲基双(膦酸)以及以此化合物作为活性成份的药物
CN1094711A (zh) 新的环己烷亚基衍生物
CN1414969A (zh) 氢化硅烷化反应的催化剂
CN1236370A (zh) 化学修饰的多肽
CN1303388A (zh) 铂配合物、其制备和治疗应用
CN1013198B (zh) 抗肿瘤的磺酰脲衍生物的制备方法
CN1898238A (zh) 噁唑烷酮－喹诺酮杂化物抗生素
CN1861603A (zh) 酞菁硅配合物及其复合物以及它们的制备和应用
CN1143861C (zh) 硅烷基-三嗪防晒剂
CN1675193A (zh) 1－甲基－2－(4－脒基苯基氨甲基)－苯并咪唑－5－基－羧酸－(n－2－吡啶基－n－2－羟基羰基乙基－酰胺的新颖前药，其制法及其作为药物制剂的用途
CN1195766C (zh) 热敏的环三磷腈－铂复合共轭物,其制备方法以及含有该共轭物的抗癌剂
CN1133293A (zh) 铂配合物和包含该铂配合物的恶性肿瘤治疗药物
CN1086809A (zh) 5-氧代-二苯并[a，d]环庚-1，4-二烯
CN1210857A (zh) 三唑衍生物及其盐
CN1028997C (zh) 新蒽环型药物衍生物或其药学上允许的酸加成盐的制法
CN1038098A (zh) 新的谷氨酸衍生物的制备方法
CN1026115C (zh) 新的s-腺苷基甲硫氨酸脱羧酶抑制剂的制备方法
CN1915222A (zh) 一种脂质体组合物及其制备方法
CN88101195A (zh) 新颖的有机铂络合物及其制备方法
CN1922193A (zh) 化学方法
CN1133641C (zh) 一种含有3'叠氮胸苷的硫代磷酰氨基酸酯化合物及其制备方法
CN1499966A (zh) 含有与含铂抗癌药物组合的去甲基斑蟊素的组合物及其用途
CN1296378C (zh) 高免疫活性 CpG－S ODN 和拮抗 CpG－S ODN 作用的 CpG－N ODN 的基因序列及其应用
CN1016345B (zh) 抗肿瘤铂配合物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned